Beranda › Kanker Kandung Kemih Non-Invasif Otot › California › Bakersfield
Uji klinis Kanker Kandung Kemih Non-Invasif Otot di Bakersfield, CA
5 studi untuk Kanker Kandung Kemih Non-Invasif Otot mencari peserta di lokasi sekitar Bakersfield (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Menerima pesertaFase 2
- Michael G Oefelein Clinical Trials ( Site 0138), Bakersfield
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
Menerima pesertaFase 1/2
- Michael G Oefelein Clinical Trials ( Site 0053), Bakersfield
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Menerima pesertaFase 2
- Michael Oefelein Clinical Trials, Bakersfield
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Menerima pesertaFase 3
- Michael Oefelein Clinical Trials, Bakersfield
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Menerima pesertaFase 1/2
- Unio Specialty Care - A Genesis Healthcare Partners Facility, Bakersfield
Uji klinis Kanker Kandung Kemih Non-Invasif Otot di kota lain
- Columbus, OH10 studi
- Dallas, TX10 studi
- New York City, NY10 studi
- Myrtle Beach, SC9 studi
- Edison, NJ9 studi
- Baltimore, MD8 studi
- Nashville, TN8 studi
- Syracuse, NY8 studi
- Houston, TX7 studi
- Indianapolis, IN7 studi
- Philadelphia, PA7 studi
- Birmingham, AL7 studi
Studi lain di Bakersfield
- Kanker Kandung Kemih7 studi
- Kanker Payudara4 studi
- Asma4 studi
- Kanker (semua jenis)3 studi
- Kanker Kolorektal3 studi
- Karsinoma In Situ3 studi
- Degenerasi Makula3 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.